BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/21/2020 1:38:19 AM | Browse: 1292 | Download: 2616
Publication Name World Journal of Clinical Oncology
Manuscript ID 55009
Country Romania
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Review
Article Title Statins in risk-reduction and treatment of cancer
Manuscript Source Invited Manuscript
All Author List Cristina I Barbalata, Lucia R Tefas, Marcela Achim, Ioan Tomuta and Alina S Porfire
ORCID
Author(s) ORCID Number
Cristina I Barbalata http://orcid.org/0000-0001-7265-7501
Lucia R Tefas http://orcid.org/0000-0001-8943-8938
Marcela Achim http://orcid.org/0000-0002-0184-3144​
Ioan Tomuta http://orcid.org/0000-0002-5094-008X
Alina S Porfire http://orcid.org/0000-0001-8475-2792
Funding Agency and Grant Number
Corresponding Author Alina S Porfire, PhD, Associate Professor, Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, “Iuliu- Hatieganu” University of Medicine and Pharmacy, 41 Victor Babes, Cluj-Napoca 400012, Romania. aporfire@umfcluj.ro
Key Words Statins; Cancer; Pleiotropic effects; Risk reduction; Clinical trials; 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase
Core Tip In the last period, statins have been increasingly studied for their anticancer properties. This review presents the application of statins in cancer management by outlining the latest in vitro and in vivo studies. The results represent the foundation of the latest clinical trials in order to search for new treatment directions in cancer therapy.
Publish Date 2020-08-21 01:38
Citation Barbalata CI, Tefas LR, Achim M, Tomuta I, Porfire AS. Statins in risk-reduction and treatment of cancer. World J Clin Oncol 2020; 11(8): 573-588
URL https://www.wjgnet.com/2218-4333/full/v11/i8/573.htm
DOI https://dx.doi.org/10.5306/wjco.v11.i8.573
Full Article (PDF) WJCO-11-573.pdf
Full Article (Word) WJCO-11-573.docx